SF1494

Purpose

This bill requires updating the list of tests used to determine the presence of heritable or congenital disorders. The goal is to keep testing current with advances in medical science and testing methods to protect and improve public health.

Main Provisions

• Periodic revisions: The commissioner must periodically revise the list of tests to be administered for detecting heritable or congenital disorders. Revisions should reflect advances in medical science, new and improved testing methods, or other factors that will improve public health.
• Factors for adding tests: When deciding whether a test must be administered, the commissioner will consider how well the analytical methods can detect the disorder, the ability to treat or prevent conditions caused by the disorder, and how severe the medical conditions are.
• Advisory committee and process: Changes can be made if recommended by the advisory committee established under section 144.1255, approved by the commissioner, and published in the State Register.
• Rulemaking exemption: Revisions are exempt from the usual rulemaking requirements in chapter 14; sections 14.385 and 14.386 do not apply.
• Specific addition: The list of tests must be revised to include metachromatic leukodystrophy (MLD).

Significance and What Changes

• Adds metachromatic leukodystrophy (MLD) to the list of conditions that may be tested for.
• Establishes a formal process for updating the testing list, including committee input, commissioner approval, and publication, while moving updates outside the standard rulemaking process.

How Revisions Work (Key Process)

• Advisory input comes from the advisory committee under section 144.1255.
• The commissioner must approve changes.
• Updated lists must be published in the State Register.

Potential Impacts

• More up-to-date screening capabilities for heritable or congenital disorders.
• Faster integration of new testing methods into practice.
• Possible changes in how families are informed about and access testing, depending on implementation.

Relevant Terms - list of tests to be administered - heritable or congenital disorder - commissioner - periodic revision - advances in medical science - new and improved testing methods - public health - analytical methods - detect the disorder - determine whether a test must be administered - ability to treat or prevent medical conditions - severity of medical conditions - advisory committee (established under section 144.1255) - State Register - rulemaking exemptions - chapter 14 - sections 14.385 and 14.386 do not apply - metachromatic leukodystrophy (MLD) - Minnesota Statutes 2024 section 144.125 subdivision 2 - section 144.1255